Aprea Therapeutics, Inc. (APRE) Earnings
|
Expand Research on APRE
| Next EPS Date | 11/5/26 | EPS Growth Rate | +59.6% |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | -83.3% |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.19 | N/A | N/A | $307.5K | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/26 | Q126 | -$0.22 | $0.00 | -$0.22 | N/A | N/A | N/A |  | | Details | |
| 3/16/26 |
Q425 | -$0.32 | $0.00 | -$0.32 | $3.34M | N/A | N/A | | | Details | |
| 11/12/25 | Q325 | -$0.47 | $0.00 | -$0.47 | $1.84M | N/A | N/A | | | Details | |
| 8/12/25 |
Q225 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.53 | $0.00 | -$0.53 | N/A | N/A | N/A | | | Details | |
| 5/14/25 | Q125 | -$0.66 | $0.00 | -$0.66 | N/A | N/A | N/A | | | Details |
